|Articles|August 1, 2014
- BioPharm International-08-01-2014
- Volume 27
- Issue 8
BioPharm International, August 2014 Issue (PDF)
Click the title above to open the BioPharm International August 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 11 years ago
Single-Domain Antibodies for Brain Targetingabout 11 years ago
Marrying Big Data with Personalized Medicineabout 11 years ago
Applying GMPs to the BioPharma Supply Chainabout 11 years ago
Changes and Challenges for Generic Drugsabout 11 years ago
Optimizing Human Performance, Part II: A Road Worth TravelingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
